ESSA Pharma Inc. (EPIX)
1.68
0.00 (0.00%)
At close: Mar 03, 2025, 3:59 PM
1.66
-0.90%
After-hours: Mar 03, 2025, 04:00 PM EST
ESSA Pharma Cash Flow Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| Net Income | -28.54M | -26.58M | -35.1M | -36.81M | -23.45M | -10.44M | -11.63M | -4.72M | -13.14M | -8.57M | -1.82M | -1.37K | -1.94K |
| Depreciation & Amortization | n/a | 118.49K | 121.79K | 109.46K | 110.32K | 18.3K | 34.49K | 46.15K | 66.18K | 39.1K | 23.39K | 24.62 | 25.41 |
| Stock-Based Compensation | 6.54M | 5.01M | 7.89K | 9.48K | 7.52K | 1.15K | 1.4M | 758.93K | 1.25M | 1.29M | 494.22K | 322.46 | 87.81 |
| Other Working Capital | -418.81K | 2.47M | -1.26M | -721.15K | -1.19M | -243.8K | 461.28K | -1.69M | 2.33M | 3.98M | 303.33K | 6.80 | n/a |
| Other Non-Cash Items | -293.46K | -664.48K | -830.78K | -35.29K | 224.07K | -1.73M | 682.76K | -4.41M | 910.1K | -5.18M | -1.12M | 67.26 | 89.14 |
| Deferred Income Tax | n/a | n/a | n/a | -107.02K | -156.09K | 14.99K | -47.71K | -7.33M | -6.71M | 24.25K | 42.88K | n/a | n/a |
| Change in Working Capital | -418.81K | 2.34M | -780.01K | 1.95M | -1.24M | -1.26M | -659.56K | -1.69M | 2.33M | 84.39K | 303.33K | 193.64 | -84.28 |
| Operating Cash Flow | -22.72M | -19.78M | -28.7M | -25.42M | -16.98M | -12.25M | -10.22M | -17.35M | -15.3M | -12.3M | -2.08M | -763.35 | -1.82K |
| Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -9.98K | -158.02K | n/a | n/a | n/a |
| Acquisitions | n/a | n/a | n/a | n/a | n/a | -246.91K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | n/a | -365.2M | -296.01M | -57.03M | -22.01M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | 131.02M | 361.68M | 242.96M | 22.01M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | -39.23M | n/a | 705.02K | -35.01K | 274.08K | 201.4K | -201.4K | n/a | n/a | 0.00 | n/a | n/a | n/a |
| Investing Cash Flow | 91.79M | -3.53M | -52.35M | -35.01M | -21.74M | -45.51K | -201.4K | n/a | -9.98K | -158.02K | n/a | n/a | n/a |
| Debt Repayment | n/a | -136.87K | -134.02K | -100.28K | -4.01M | -2.81M | -1.99M | 8M | n/a | n/a | 911K | n/a | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 925.51K | 68.71K | 386.76K | -7.91M | -3.21M | 17.77M | -2.74M | 4.33M | 2.74M | -617.46K | 2.56M | n/a | 2.4K |
| Financial Cash Flow | 925.51K | -68.16K | 252.74K | 141.99M | 41.78M | 50.81M | 21.31M | 12.33M | 22.74M | 11.07M | 5.66M | n/a | 2.4K |
| Net Cash Flow | 70.01M | -23.37M | -80.75M | 81.5M | 3M | 38.49M | 10.87M | -5.03M | 7.41M | -1.52M | 3.47M | -763.35 | 574.40 |
| Free Cash Flow | -22.72M | -19.78M | -28.7M | -25.42M | -16.98M | -12.25M | -10.22M | -17.35M | -15.31M | -12.46M | -2.08M | -763.35 | -1.82K |